|Trade names||Debridat, Recutin, Polybutin, others|
|AHFS/Drugs.com||International Drug Names|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||387.47 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
The major product from drug metabolism of trimebutine in human beings is nortrimebutine, which comes from removal of one of the methyl groups attached to the nitrogen atom. Trimebutine exerts its effects in part due to causing a premature activation of phase III of the migrating motor complex in the digestive tract.
Both trimebutine and its metabolite are commercially available.
|This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.|